The hypolipidemic effect of calcium-containing compounds and vitamin D 2  in the rat.
D000818:Animals; D002118:Calcium / Q000097:blood / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D002119:Calcium Carbonate / Q000494:pharmacology; D002784:Cholesterol / Q000097:blood*; D003677:Deficiency Diseases / Q000188:drug therapy; D004036:Diet, Atherogenic; D004041:Dietary Fats; D004872:Ergocalciferols / Q000494:pharmacology*; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005243:Feces / Q000032:analysis; D005989:Glycerides / Q000378:metabolism; D006949:Hyperlipidemias / Q000188:drug therapy; D008274:Magnesium / Q000097:blood; D008297:Male; D008660:Metabolism / Q000187:drug effects; D051381:Rats; D013261:Sterols / Q000378:metabolism; D014280:Triglycerides / Q000097:blood*
D004041:Dietary Fats; D004872:Ergocalciferols; D005230:Fatty Acids, Nonesterified; D005989:Glycerides; D013261:Sterols; D014280:Triglycerides; D002784:Cholesterol; D002119:Calcium Carbonate; D008274:Magnesium; D002118:Calcium